Courage Capital Management’s Q32 Bio QTTB Stock Holding History

Courage Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-556	Closed	-$36K	–	41
2021 Q4	$36K	Hold	556	–	–	0.02%	39
2021 Q3	$79K	Hold	556	–	–	0.04%	41
2021 Q2	$73K	Hold	556	–	–	0.04%	39
2021 Q1	$94K	Buy	+556	New	+$117K	0.07%	40
2020 Q2	–	Sell	-556	Closed	-$155K	–	31
2020 Q1	$155K	Hold	556	–	–	0.35%	26
2019 Q4	$207K	Hold	556	–	–	0.63%	13
2019 Q3	$181K	Hold	556	–	–	0.29%	16
2019 Q2	$196K	Hold	556	–	–	0.33%	14
2019 Q1	$277K	Hold	556	–	–	0.24%	14
2018 Q4	$224K	Hold	556	–	–	0.17%	16
2018 Q3	$229K	Buy	+556	New	+$189K	0.12%	23

Other funds holding QTTB

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

Courage Capital Management's QTTB Position: Q1 2022 in Review

Courage Capital Management sold out of Q32 Bio (QTTB) in Q1 2022, closing a stake of 556 shares — an estimated $36K sold.

Courage Capital Management first reported a position in QTTB in Q3 2018 and held it in 11 quarters. The position peaked at $277K in Q1 2019. 106 funds tracked by Wall St. Rank hold QTTB as of Q1 2022.

Courage Capital Management reported no remaining Q32 Bio position as of Q1 2022 after selling out during the quarter.
Courage Capital Management sold 556 Q32 Bio shares in Q1 2022, an estimated $36K.
Courage Capital Management first reported a position in Q32 Bio in Q3 2018 and held it in 11 quarters.
Courage Capital Management's Q32 Bio position peaked at $277K in Q1 2019.
106 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2022.

Based on Courage Capital Management's 13F filing for Q1 2022, filed 16 May 2022.